AKT-FD Tablet 3's

AKT-FD Tablet is used to treat tuberculosis. Tuberculosis is an infectious disease that mainly affects the lungs, but it can also spread to other body parts such as kidneys, brain, spine and bone marrow. AKT-FD Tablet does not work against infections caused by the virus, including cold and flu.

AKT-FD Tablet is a combination of four anti-tuberculosis drugs: Rifampicin, isoniazid, pyrazinamide and ethambutol. Isoniazid prevents the formation of the bacterial cell wall. At the same time, rifampicin inactivates a bacterial enzyme (RNA-polymerase), which is required by TB bacteria (Mycobacterium tuberculosis) to make essential proteins and to reproduce. Ethambutol and pyrazinamide work by slowing the growth of bacteria. Altogether, they kill the bacteria and treat the infection.

The dose and duration of AKT-FD Tablet can vary depending on your condition and the severity of the infection. In some cases, you may experience certain common side effects such as weakness, nausea, vomiting, malaise (feeling of discomfort), fatigue and vision problems. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Avoid foods and drinks containing histamine or tyramine, such as cured meat, matured cheese, soya, tuna, salmon, mackerel, wine and beer, while taking AKT-FD Tablet as they might cause interaction. Maintain a gap of one hour between AKT-FD Tablet and antacid medicines. Consult your doctor before taking AKT-FD Tablet if you are pregnant. Avoid breastfeeding while taking AKT-FD Tablet as it passes into breast milk. AKT-FD Tablet is not recommended for use in children. AKT-FD Tablet may cause dizziness and vision problems, so drive only if you are alert. Avoid consuming alcohol along with AKT-FD Tablet as it might lead to liver problems and increased dizziness.

AKT-FD Tablet belongs to the group of medicines called anti-tuberculosis drugs primarily used to treat and prevent tuberculosis. AKT-FD Tablet is a combination of four anti-tuberculosis drugs: Rifampicin, isoniazid, pyrazinamide and ethambutol. Isoniazid prevents the formation of the bacterial cell wall. At the same time, rifampicin inactivates a bacterial enzyme (RNA-polymerase), which is required by TB bacteria (Mycobacterium tuberculosis) to make essential proteins and reproduce. Ethambutol and pyrazinamide work by slowing the growth of bacteria. Altogether, they kill the bacteria and treat the infection.

Do not take AKT-FD Tablet if you are allergic to any of its contents, if you have jaundice or if you are taking HIV medicines (saquinavir or ritonavir). Before starting AKT-FD Tablet, please inform your doctor if you have diabetes, epilepsy, gout, mental health problems, HIV infection, malnutrition, peripheral neuropathy, porphyria, bleeding problems, kidney or liver problems. Consult your doctor before taking AKT-FD Tablet if you are pregnant. Avoid breastfeeding while taking AKT-FD Tablet as it passes into breast milk. AKT-FD Tablet is not recommended for use in children. AKT-FD Tablet may cause dizziness and vision problems, so drive with caution. Avoid consuming alcohol along with AKT-FD Tablet as it might lead to liver problems and increased dizziness.